IL32521A - Manufacture of interferon-promoting substances - Google Patents
Manufacture of interferon-promoting substancesInfo
- Publication number
- IL32521A IL32521A IL32521A IL3252169A IL32521A IL 32521 A IL32521 A IL 32521A IL 32521 A IL32521 A IL 32521A IL 3252169 A IL3252169 A IL 3252169A IL 32521 A IL32521 A IL 32521A
- Authority
- IL
- Israel
- Prior art keywords
- corn
- coli
- cells
- steep
- coll
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 13
- 239000002799 interferon inducing agent Substances 0.000 title description 3
- 230000012010 growth Effects 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 12
- 239000001963 growth medium Substances 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 10
- 229920002477 rna polymer Polymers 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 description 31
- 241000588724 Escherichia coli Species 0.000 description 27
- 239000002609 medium Substances 0.000 description 22
- 102000014150 Interferons Human genes 0.000 description 10
- 108010050904 Interferons Proteins 0.000 description 10
- 241000700605 Viruses Species 0.000 description 10
- 229940079322 interferon Drugs 0.000 description 10
- 239000006166 lysate Substances 0.000 description 9
- 240000008042 Zea mays Species 0.000 description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 8
- 235000005822 corn Nutrition 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 239000012137 tryptone Substances 0.000 description 6
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 4
- 239000000411 inducer Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/802—Logarithmic growth phase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/811—Interferon
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/848—Escherichia
- Y10S435/849—Escherichia coli
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74468768A | 1968-07-15 | 1968-07-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL32521A0 IL32521A0 (en) | 1969-09-25 |
| IL32521A true IL32521A (en) | 1972-12-29 |
Family
ID=24993616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL32521A IL32521A (en) | 1968-07-15 | 1969-07-01 | Manufacture of interferon-promoting substances |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3583893A (de) |
| BE (1) | BE736050A (de) |
| BR (1) | BR6910680D0 (de) |
| CH (1) | CH529834A (de) |
| DE (1) | DE1935667A1 (de) |
| DK (1) | DK126430B (de) |
| ES (1) | ES369219A1 (de) |
| FR (1) | FR2022103A1 (de) |
| GB (1) | GB1226907A (de) |
| IL (1) | IL32521A (de) |
| NL (1) | NL6909837A (de) |
| SE (1) | SE365245B (de) |
| ZA (1) | ZA694278B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3819482A (en) * | 1972-05-08 | 1974-06-25 | J Semancik | Method of preparing high yields of double-stranded ribonucleic acid |
-
1968
- 1968-07-15 US US744687A patent/US3583893A/en not_active Expired - Lifetime
-
1969
- 1969-06-17 ZA ZA694278A patent/ZA694278B/xx unknown
- 1969-06-26 NL NL6909837A patent/NL6909837A/xx unknown
- 1969-07-01 IL IL32521A patent/IL32521A/en unknown
- 1969-07-07 GB GB1226907D patent/GB1226907A/en not_active Expired
- 1969-07-07 ES ES369219A patent/ES369219A1/es not_active Expired
- 1969-07-08 SE SE09662/69A patent/SE365245B/xx unknown
- 1969-07-14 BE BE736050D patent/BE736050A/xx unknown
- 1969-07-14 DK DK379569AA patent/DK126430B/da unknown
- 1969-07-14 DE DE19691935667 patent/DE1935667A1/de active Pending
- 1969-07-14 CH CH1077169A patent/CH529834A/de not_active IP Right Cessation
- 1969-07-14 BR BR210680/69A patent/BR6910680D0/pt unknown
- 1969-07-15 FR FR6924007A patent/FR2022103A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ZA694278B (en) | 1971-01-27 |
| IL32521A0 (en) | 1969-09-25 |
| NL6909837A (de) | 1970-01-19 |
| SE365245B (de) | 1974-03-18 |
| DK126430B (da) | 1973-07-16 |
| FR2022103A1 (de) | 1970-07-31 |
| BR6910680D0 (pt) | 1973-02-22 |
| CH529834A (de) | 1972-10-31 |
| US3583893A (en) | 1971-06-08 |
| ES369219A1 (es) | 1971-06-16 |
| DE1935667A1 (de) | 1970-03-12 |
| GB1226907A (de) | 1971-03-31 |
| BE736050A (de) | 1970-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0365598B1 (de) | Ärztliche antimikrobielle polypeptide, deren verwendung und verfahren zur herstellung | |
| DE3891417C5 (de) | Verfahren zur Veränderung eines L-Threonin produzierenden Mikroorganismus und Verwendung eines so erhaltenen Mikroorganismus zur Herstellung von L-Threonin | |
| Zweig et al. | Cleavage of head and tail proteins during bacteriophage T5 assembly: selective host involvement in the cleavage of a tail protein | |
| EP0417254B1 (de) | Verfahren zur herstellung von beta-1,3-glucan in algen | |
| JPS63164891A (ja) | 酵母によるヒト腫瘍壊死因子の生産方法 | |
| CN1062481C (zh) | 人类免疫缺陷病毒活性抑制剂 | |
| Israel | The production of inactive phage P22 particles following induction | |
| Notani et al. | Inducible repair system in Haemophilus influenzae unaccompanied by mutation | |
| IL32521A (en) | Manufacture of interferon-promoting substances | |
| Goreau et al. | Calcium uptake by a coral | |
| Bang et al. | Chronic infections produced in cultured cell strains by the virus of Eastern equine encephalomyelitis | |
| CN113201506B (zh) | 一株高效裂解碳青霉烯耐药肺炎克雷伯菌噬菌体及其应用 | |
| Voltolina et al. | Zeolitic products as enrichment for cultures of a marine microalga | |
| Taketo | Sensitivity of Escherichia coli to viral nucleic acid, X. Ba2+-induced competence for transfecting DNA | |
| US3582469A (en) | Production of double-stranded ribonucleic acid | |
| Kylberg et al. | Characterization of transduction by bacteriophage T1: time of production and density of transducing particles | |
| GB2159821A (en) | Transformation of lower eukaryotic cells | |
| US3775398A (en) | N-oxide of double stranded rna | |
| CN110251656B (zh) | 多肽化合物的制备方法及其应用和hiv潜伏激活的药物 | |
| Altenbern | Critical factors influencing growth of L forms of Proteus mirabilis | |
| Rubio et al. | An improved medium for the isolation of Cryptococcus neoformans from pigeon droppings | |
| DE2334314A1 (de) | Verfahren zur herstellung von polynucleotiden auf mikrobiologischem weg | |
| Arnstein et al. | The penicillin produced by Aspergillus parasiticus | |
| Nermut et al. | Changes in the dry weight and the deoxyribonucleic acid content of Proteus vulgaris caused by penicillin | |
| DE2903852A1 (de) | Mikrobiologischer abbau von acrylnitril in waessrigen dispersionen |